Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

December 1982

Volume 398 Opioids in Mental Illness: Theories, Clinical Observations, and Treatment Possibilities

Pages xi–xi, 1–510

    1. INTRODUCTORY REMARKS (page xi)

      Karl Verebey

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39467.x

    2. Part I. Historical Perspectives: OPIATE USE IN ENGLAND, 1800–1926 (pages 1–11)

      Virginia Berridge

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39468.x

    3. HISTORY OF OPIATE USE IN THE ORIENT AND THE UNITED STATES (pages 12–23)

      E. Leong Way

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39469.x

    4. OPIATES AND SEVERELY DISTURBED PATIENTS (pages 58–64)

      Bernard Salzman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39474.x

    5. TREATMENT OF MIXED ABUSERS IN METHADONE MAINTENANCE: ROLE OF PSYCHIATRIC FACTORS (pages 65–78)

      A. Thomas McLellan, George E. Woody, Bradley D. Evans and Charles P. O'Brien

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39475.x

    6. THE POPPY: THERAPEUTIC POTENTIAL IN CASES OF DEMENTIA WITH DEPRESSION (pages 79–82)

      D. Wilfred Abse, William J. Rheuban and Salman Akhtar

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39476.x

    7. METHADONE: AN EFFECTIVE AGENT IN MANAGING INTRACTABLE PAIN AS A SYMPTOM OF PSYCHOTIC ANGER (pages 83–86)

      Gilbert H. Berken, Melvin M. Stone and Shirley K. Stone

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39477.x

    8. METHADONE TREATMENT OF PENTAZOCINE ABUSE (pages 87–95)

      Jerrold S. Maxmen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39478.x

    9. NALOXONE AND NALTREXONE IN MENTAL ILLNESS AND TARDIVE DYSKINESIA (pages 97–102)

      Jan Volavka, Brian Anderson and Gabriel Koz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39480.x

    10. THE EFFECT OF CODEINE ON INVOLUTIONAL AND SENILE DEPRESSION (pages 103–105)

      Ervin Varga, A. Arthur Sugerman and Jeffrey Apter

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39481.x

    11. NALOXONE AND NALTREXONE IN MENTAL ILLNESS (pages 106–107)

      Jan V. Volavka and Ervin Varga

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39482.x

    12. POSSIBLE ANTIDEPRESSIVE EFFECTS OF OPIOIDS: ACTION OF BUPRENORPHINE (pages 108–112)

      H. M. Emrich, P. Vogt and A. Herz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39483.x

    13. A POSSIBLE OPIOID RECEPTOR DYSFUNCTION IN SOME DEPRESSIVE DISORDERS (pages 113–119)

      Irl Extein, A. L. C. Pottash and Mark S. Gold

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39484.x

    14. THE USE OF ANTIDEPRESSANTS WITH METHADONE IN DEPRESSED MAINTENANCE PATIENTS (pages 120–127)

      George E. Woody, Charles P. O'Brien, A. Thomas McLellan, Martin Marcovici and Bradley D. Evans

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39485.x

    15. ANTIMANIC, ANTIDEPRESSANT, AND ANTIPANIC EFFECTS OF OPIATES: CLINICAL, NEUROANATOMICAL, AND BIOCHEMICAL EVIDENCE (pages 140–150)

      Mark S. Gold, A. Carter Pottash, Donald Sweeney, David Martin and Irl Extein

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39488.x

    16. OPIOID PEPTIDES IN THE HIPPOCAMPUS: ANATOMICAL AND PHYSIOLOGICAL CONSIDERATIONS (pages 207–220)

      Steven J. Henriksen, Guy Chouvet, Jacqueline McGinty and Floyd E. Bloom

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39495.x

    17. BRAIN ENDORPHINS: POSSIBLE ROLE IN LONG-TERM MEMORY (pages 221–229)

      James D. Belluzzi and Larry Stein

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39496.x

    18. BIOBEHAVIORAL BASES OF THE REINFORCING PROPERTIES OF OPIATE DRUGS (pages 241–259)

      Conan Kornetsky and George Bain

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39498.x

    19. ACTIVATION OF OPIOID-CONTAINING SYSTEMS DURING GESTATION (pages 302–307)

      Alan R. Gintzler

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39502.x

    20. METABOLISM OF ENKEPHALIN ANALOGUES AND SURROGATES HAVING ENHANCED PHARMACOLOGIC ACTIVITIES (pages 308–326)

      Neville Marks, Myron Benuck, Martin J. Berg and Len Sachs

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39503.x

    21. MULTIPLE OPIATE RECEPTORS AND THEIR DIFFERENT LIGAND PROFILES (pages 340–351)

      Martin W. Adler

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39505.x

    22. ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHPATHOLOGY (pages 352–365)

      M. S. Buchsbaum, V. I. Reus, G. C. Davis, H. H. Holcomb, J. Cappelletti and E. Silberman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39506.x

    23. ALTERED PAIN PERCEPTION AND CEREBROSPINAL ENDORPHINS IN PSYCHIATRIC ILLNESS (pages 366–373)

      Glenn C. Davis, Monte S. Buchsbaum, Dieter Naber, David Pickar, Robert Post, Daniel van Kammen and William E. Bunney Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39507.x

    24. ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHOPATHOLOGY (pages 374–376)

      M. S. Buchsbaum, V. I. Reus, G. C. Davis, H. H. Holcomb, J. Cappelletti, E. Silberman, Glenn C. Davis, Monte S. Buchsbaum, Dieter Naber, David Pickar, Robert Post, Daniel van Kammen and William E. Bunney Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39508.x

    25. ENDORPHIN LEVELS IN OPIOID-DEPENDENT HUMAN SUBJECTS: A LONGITUDINAL STUDY (pages 377–387)

      C. P. O'Brien, L. Terenius, A. Wahlström, A. T. McLellan and W. Krivoy

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39509.x

    26. ENDORPHINS IN THE CEREBROSPINAL FLUID OF PSYCHIATRIC PATIENTS (pages 399–412)

      David Pickar, Dieter Naber, Robert M. Post, Daniel P. van Kammen, Walter Kaye, David R. Rubinow, James C. Ballenger and William E. Bunney Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39511.x

    27. β-ENDORPHIN IMMUNOREACTIVITY IN THE PLASMA OF PSYCHIATRIC PATIENTS RECEIVING ELECTROCONVULSIVE TREATMENT (pages 413–423)

      Charles E. Inturrisi, George Alexopoulos, Robert Lipman, Kathleen Foley and Jean Rossier

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39512.x

    28. CLINICAL AND EXPERIMENTAL STUDIES OF STRESS AND THE ENDOGENOUS OPIOID SYSTEM (pages 424–432)

      Martin R. Cohen, David Pickar, Michel Dubois, John Numberger, Yolanda Roth, Robert M. Cohen, Elliot Gershon and William E. Bunney Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39513.x

    29. CLINICAL PHARMACOLOGY OF β-ENDORPHIN IN DEPRESSION AND SCHIZOPHRENIA (pages 434–447)

      Don H. Catlin, David A. Gorelick and Robert H. Gerner

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39515.x

    30. STUDIES OF β-ENDORPHIN IN PSYCHIATRIC PATIENTS (pages 448–459)

      Philip A. Berger and Jack D. Barchas

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39516.x

    31. β-ENDORPHIN ADMINISTRATION TO ACUTE SCHIZOPHRENIC PATIENTS: A DOUBLE BLIND STUDY (pages 460–469)

      Bertalan Pethö, László Gráf, István Karczag, János Borvendég, István Bitter, István Barna, Ilona Hermann, Judit Tolna and Krisztina Baraczka

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39517.x

    32. CLINICAL TRIAL OF DES-TYROSYL-γ-ENDORPHIN IN MENTAL ILLNESS (pages 470–477)

      H. M. Emrich, M. Zaudig, W. Kissling, G. Dirlich, D. V. Zerssen and A. Herz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39518.x

    33. THE USE OF THE SYNTHETIC PEPTIDES γ-TYPE ENDORPHINS IN MENTALLY ILL PATIENTS (pages 478–495)

      Jan M. van Ree, Wim M. A. Verhoeven, David de Wied and Herman M. van Praag

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39519.x

    34. CLINICAL, ELECTROPHYSIOLOGICAL, AND BIOCHEMICAL EFFECTS OF DES-TYROSINE-γ-ENDORPHIN IN PSYCHIATRIC PATIENTS (pages 496–508)

      John Metz, Daniel A. Busch and Herbert Y. Meltzer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39520.x

    35. CLOSING REMARKS (pages 509–510)

      Karl Verebey

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1982.tb39521.x

SEARCH

SEARCH BY CITATION